People: argenx SE (ARGX.OQ)

ARGX.OQ on NASDAQ Stock Exchange Global Select Market

1:30am IST
Change (% chg)

$-2.62 (-1.04%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

de Haard, Hans 

Prof. Hans de Haard Ph.D. serves as Chief Scientific Officer of the Company. Prof. de Haard has been active in the antibody engineering field since 1989. He also serves as a Professor of Immunology at University of Franche Comte (France). Prof. de Haard holds an M. Sc. in biochemistry from the Higher Professional Education for Laboratory Technicians (Oss, the Netherlands) of Universiteit Maastricht, M. Sc. in chemistry from the Institute of Technology of Erasmus Universiteit Rotterdam (Rotterdam, the Netherlands) and a Ph. D. in molecular immunology from Universiteit Maastricht.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --